Several mouse studies have shown significantly (17 experiments) or non-significantly (4 experiments) improved tumour control or survival with upfront anti-IL-6 plus ICI compared to ICI alone (Supplementary table 6)102,104–110. The gene discussed is IL6; the disease is neoplasm.